HaploX, a global leader in next-generation sequencing solutions, today announced the commercial launch of four highly-anticipated reagent kits designed to accelerate precision oncology from discovery to post-treatment monitoring. The new kits—CorePanel: Clinical 136, StarPanel: Clinical 1326, mClear: Personalized MRD, and mClean (Digestive-Tract): fixed panel MRD—deliver comprehensive genomic profiling and ultra-sensitive minimal residual disease (MRD) detection for solid-tumor patients and their clinicians.
Unlock exclusive discounts on our research servicesby signing a contractand sending us samples before December 25,2025!
Leveraging our self-developed Fastp and cutting-edge data analysis tools, our advanced multi-omics platform delivers precision discovery through end-to-end services—whether starting from raw data or physical samples. Supported by a dedicated PhD-level scientific team, we provide highly customized analytical solutions to address complex research challenges. Our expertise is demonstrated by a track record of contributions to over 300 SCI publications, and reinforced by 95+ software copyrights and 86 patents, reflecting our commitment to innovation and scientific excellence.
The ESMO Congress 2025 will be held in a hybrid format (both online and in-person) in Berlin, Germany, from 17 to 21 October 2025 (Central European Time). This conference aims to disseminate cutting-edge research advances in the field of oncology and provide high-level medical education and valuable academic exchange opportunities for global oncology scholars, oncologists, and other related healthcare professionals.
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting will be held from May 30 to June 3 (Eastern Time, ET) in Chicago, USA. As the world s largest, most academically rigorous, and authoritative conference in clinical oncology, the ASCO Annual Meeting brings together physicians, professionals, patient advocates, industry representatives, and major media from across the global oncology field to focus on cutting-edge international research discoveries and clinical trial results.